Kolexia
Barbieux Sarah Hématologie
Barbieux Sarah
Hématologie
Centre Hospitalier de Dunkerque
Dunkerque, France
41 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome T Leucémies Lymphome T périphérique Leucémie-lymphome lymphoblastique à précurseurs B et T Amyloïdose Leucémie aigüe myéloïde Hypoalbuminémie Lymphome à cellules du manteau

Collaborateurs

Voir plus
Escure Guillaume
Escure Guillaume
Hôpital Jeanne de Flandre, Lille, France
Bossard Jean-Baptiste
Bossard Jean-Baptiste
Centre Hospitalier de Lens, Lens, France
Carpentier Benjamin
Carpentier Benjamin
Hôpital Saint Vincent de Paul Lille, Lille, France
Chauvet Paul
Chauvet Paul
Hôpital Huriez, Lille, France

Industries

Voir plus
Novartis
7 collaboration(s)
Dernière en 2023
Abbvie
6 collaboration(s)
Dernière en 2023
Janssen
6 collaboration(s)
Dernière en 2023
AstraZeneca
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Study of Lacutamab in Peripheral T-cell Lymphoma: A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell Lymphoma
Essai Clinique (Innate Pharma)   04 décembre 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica   30 novembre 2023
TRANSCRIPT: Transplantation After Complete Response In Patients With T-cell Lymphoma
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in elderly mantle cell lymphoma patients. For the LYSA group.
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Haematologica   09 mars 2023
Replacing the Anthracycline By Gemtuzumab Ozogamicin in Older Patients with De Novo Standard-Risk Acute Myeloid Leukemia Treated Intensively - Results of the Randomized ALFA1401-Mylofrance 4 Study
Blood   23 novembre 2021
Impact of Central Nervous System Involvement in Adult Patients with Acute Lymphoblastic Leukemia Treated in a Pediatrics-Inspired Protocol - a Graall Study
Blood   23 novembre 2021
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
European journal of haematology   01 juin 2021
Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?
Blood advances   31 mai 2021
Treatment with Temozolomide and Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL)
Blood   05 novembre 2020